Mayne Pharma Services Information

We are a customer-focused, full-service, global, contract development and manufacturing organisation (CDMO) specialising in pharmaceutical development of oral and topical dosage forms. Part of Mayne Pharma Group Limited, we have a 40-year proud history of successfully developing and manufacturing oral and topical products. We manufacture for the global market to rigorous pharma industry standards, using best practice techniques and specialised equipment. With over 30 existing customers, we partner with clients to help take their pharmaceutical products from concept to commercialisation quickly and cost-effectively. Our highly-skilled and dedicated team of scientists and project managers offers individualised contract development and manufacturing services for our clients. This includes pharmaceutical formulation, analytical development, clinical trial supplies, scale-up of new formulations, technology transfer of products and commercial production. We are FDA and TGA accredited and have mutual agreements with MHRA, Health Canada and other European and Asian authorities. We have a proven commercialisation track record - demonstrated by more than 70 product launches globally over the last decade. Our facility is located in South Australia, meaning you may be eligible to take advantage of current Australian Government tax incentives. Our proven experience in generating intellectual property can help accelerate your program’s patent protection goals. If you’re looking for a tailored solution for your pharmaceutical project, we’re here to support you take the next step.